Clinical Trials Archives - Page 5 of 7

The Corsano system for early Sepsis detection (CORSEP) trial.

by Matthias Burel | Nov 1, 2023 | Clinical Trials

TitleThe Corsano system for early Sepsis detection (CORSEP) trial. A collaborative trial between Universitätsmedizin Greifswald and Corsano Health B.V. BackgroundSepsis is a life-threatening condition triggered by an overwhelming immune response to infection that...

Differences in Acceptability of Music Therapy Sessions Played Live Compared to a Recording Thereof

by Matthias Burel | Oct 31, 2023 | Clinical Trials

TitleDifferences in Acceptability of Music Therapy Sessions Played Live Compared to a Recording Thereof. Exploring the Feasibility and Acceptability of Music Therapy in Palliative Care Settings. BackgroundThe present study seeks to assess differences in feasibility...

Early Detection of Inflammation Induced by Lipopolysaccharide in Healthy Volunteers via Wearable Sensors

by Matthias Burel | Oct 29, 2023 | Clinical Trials

Topic Improving health outcomes in areas such as early identification of infection, individual vaccine responses, and the monitoring of autoimmune conditions and immune-oncology therapies require medical approaches that transcend outdated, century-old practices for...

Digital Biomarker Discovery and Management of Individual Physiological Activity and Performance Measures in an Isolated Mars Analogue

by Matthias Burel | Oct 28, 2023 | Clinical Trials

Topic Investigation of Corsano CardioWatch 287-2B devices for monitoring and maintaining peak cognitive performance levels in healthy adults living in isolation to improve spaceflight readiness. Objective To predict adaptive/maladaptive changes in crew member...

Characterizing normal and abnormal autonomic physiology in relation to POTS in humans with hypermobile Elhers-Danlos Syndrome

by Matthias Burel | Oct 27, 2023 | Clinical Trials

Topic Investigation of Corsano CardioWatch 287-2B devices for monitoring Elhers-Danlos Syndrome (EDS) patient physiology in both stable and symptomatic states for digital biomarker and personalized predictive model development Objective To characterize and predict the...

Real-Time Technology-Driven Prediction Modelling of Treatment-Related Adverse Events during Intensive Hematological Care in the Outpatient Setting

by Matthias Burel | Oct 26, 2023 | Clinical Trials

RationalePatients receiving intensive therapies for hematological malignancies, such as chimeric antigen receptor (CAR) T-cell therapy or autologous hematopoietic stem cell transplantation (HSCT), frequently experience adverse effects caused by high-dose chemotherapy,...